CYTOF: Altamira Therapeutics Ltd Financial Statements
Balance sheet, income statement, and cash flow statements for Altamira Therapeutics Ltd (CYTOF).
CHF1.38M Market Cap.
CYTOF Market Cap. (MRY)
CYTOF Shares Outstanding (MRY)
CYTOF Assets (MRY)
Total Assets
CHF7.69M
Total Liabilities
CHF1.24M
Total Investments
CHF2.42M
CYTOF Income (MRY)
Revenue
CHF0
Net Income
-CHF3.87M
Operating Expense
CHF5.92M
CYTOF Cash Flow (MRY)
CF Operations
-CHF11.51M
CF Investing
CHF1.44M
CF Financing
CHF10.62M
CYTOF Balance Sheet (MRY)
Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
Total Assets | CHF7,694,259 (22.08%) | CHF6,302,765 (-67.12%) | CHF19,170,321 (-7.83%) | CHF20,799,367 (125.44%) |
Assets Current | CHF1,223,154 (-30.86%) | CHF1,768,993 (-56.77%) | CHF4,091,624 (-64.78%) | CHF11,617,320 (389.38%) |
Assets Non-Current | CHF6,471,105 (42.73%) | CHF4,533,772 (-69.93%) | CHF15,078,697 (64.22%) | CHF9,182,047 (34.00%) |
Goodwill & Intangible Assets | CHF3,893,681 (0.00%) | CHF3,893,681 (-72.80%) | CHF14,314,877 (57.04%) | CHF9,115,410 (34.73%) |
Shareholders Equity | CHF6,458,717 (177.68%) | -CHF8,314,811 (-163.78%) | CHF13,036,251 (-22.26%) | CHF16,769,890 (177.83%) |
Property Plant & Equipment Net | CHF80,111 (-82.03%) | CHF445,828 (-21.05%) | CHF564,715 (1110.90%) | CHF46,636 (-30.05%) |
Cash & Equivalents | CHF617,409 (3910.45%) | CHF15,395 (-98.44%) | CHF984,191 (-91.26%) | CHF11,258,870 (713.08%) |
Accumulated Other Comprehensive Income | CHF0 (0%) | CHF0 (0%) | CHF62,069 (1.26%) | CHF61,297 (322.37%) |
Deferred Revenue | CHF0 (0%) | CHF932,200 (0%) | CHF0 (0%) | CHF0 (0%) |
Total Investments | CHF2,417,312 (0%) | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) |
Investments Current | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) |
Investments Non-Current | CHF2,417,312 (0%) | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) |
Inventory | CHF0 (0%) | CHF11,644 (-98.61%) | CHF839,221 (0%) | CHF0 (0%) |
Trade & Non-Trade Receivables | CHF74,823 (-90.19%) | CHF762,512 (10.02%) | CHF693,086 (757.13%) | CHF80,861 (-77.24%) |
Trade & Non-Trade Payables | CHF440,414 (-91.04%) | CHF4,914,404 (32.90%) | CHF3,697,723 (384.98%) | CHF762,453 (-18.74%) |
Accumulated Retained Earnings (Deficit) | -CHF18,046,002 (91.04%) | -CHF201,431,272 (-14.65%) | -CHF175,686,937 (-9.37%) | -CHF160,635,879 (-5.14%) |
Tax Assets | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) |
Tax Liabilities | CHF0 (0%) | CHF125,870 (-11.66%) | CHF142,484 (13.20%) | CHF125,865 (-14.46%) |
Total Debt | CHF99,659 (-98.43%) | CHF6,331,282 (999.68%) | CHF575,736 (9.89%) | CHF523,920 (0%) |
Debt Current | CHF99,659 (-98.34%) | CHF5,987,653 (5140.79%) | CHF114,251 (-78.19%) | CHF523,920 (0%) |
Debt Non-Current | CHF0 (0%) | CHF343,629 (-25.54%) | CHF461,485 (0%) | CHF0 (0%) |
Total Liabilities | CHF1,235,542 (-91.55%) | CHF14,617,576 (138.30%) | CHF6,134,070 (52.23%) | CHF4,029,477 (26.32%) |
Liabilities Current | CHF888,914 (-93.10%) | CHF12,879,671 (164.98%) | CHF4,860,549 (60.42%) | CHF3,029,918 (33.00%) |
Liabilities Non-Current | CHF346,628 (-80.05%) | CHF1,737,905 (36.46%) | CHF1,273,521 (27.41%) | CHF999,559 (9.61%) |
CYTOF Income Statement (MRY)
Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
Revenues | CHF0 (0%) | CHF305,616 (378.41%) | CHF63,882 (0%) | CHF0 (0%) |
Cost of Revenue | CHF0 (0%) | CHF1,443,855 (-35.56%) | CHF2,240,554 (0%) | CHF0 (0%) |
Selling General & Administrative Expense | CHF3,136,275 (-47.95%) | CHF6,025,933 (-6.50%) | CHF6,444,794 (148.39%) | CHF2,594,662 (-34.04%) |
Research & Development Expense | CHF3,035,413 (-84.57%) | CHF19,677,756 (135.36%) | CHF8,360,821 (192.03%) | CHF2,862,979 (-13.90%) |
Operating Expenses | CHF5,916,099 (-76.33%) | CHF24,995,377 (71.30%) | CHF14,591,398 (165.16%) | CHF5,502,781 (-24.20%) |
Interest Expense | CHF1,668,475 (82.97%) | CHF911,869 (380.70%) | CHF189,695 (40.36%) | CHF135,151 (372.09%) |
Income Tax Expense | CHF0 (0%) | -CHF10,329 (-147.78%) | CHF21,620 (201.58%) | -CHF21,284 (89.02%) |
Net Loss Income from Discontinued Operations | -CHF3,400,865 (0%) | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) |
Consolidated Income | -CHF3,869,173 (85.41%) | -CHF26,528,411 (-55.51%) | -CHF17,058,443 (-108.03%) | -CHF8,200,165 (-23.65%) |
Net Income to Non-Controlling Interests | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) |
Net Income | -CHF3,869,173 (85.41%) | -CHF26,528,411 (-55.51%) | -CHF17,058,443 (-108.03%) | -CHF8,200,165 (-23.65%) |
Preferred Dividends Income Statement Impact | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) |
Net Income Common Stock | -CHF3,869,173 (85.41%) | -CHF26,528,411 (-55.51%) | -CHF17,058,443 (-108.03%) | -CHF8,200,165 (-23.65%) |
Weighted Average Shares | CHF397,700 (-53.39%) | CHF853,213 (25.08%) | CHF682,156 (169.68%) | CHF252,954 (169.85%) |
Weighted Average Shares Diluted | - | - | - | - |
Earning Before Interest & Taxes (EBIT) | -CHF2,200,698 (91.41%) | -CHF25,626,871 (-52.11%) | -CHF16,847,128 (-108.34%) | -CHF8,086,298 (-18.97%) |
Gross Profit | CHF0 (0%) | -CHF1,138,239 (47.71%) | -CHF2,176,672 (0%) | CHF0 (0%) |
Operating Income | -CHF5,916,099 (77.36%) | -CHF26,133,616 (-55.85%) | -CHF16,768,070 (-204.72%) | -CHF5,502,781 (24.20%) |
CYTOF Cash Flow Statement (MRY)
Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
Net Cash Flow from Investing | CHF1,444,869 (167.46%) | -CHF2,141,837 (38.89%) | -CHF3,505,056 (-51.41%) | -CHF2,314,974 (22.85%) |
Net Cash Flow from Financing | CHF10,621,615 (8.03%) | CHF9,831,995 (48.66%) | CHF6,613,724 (-61.01%) | CHF16,961,069 (129.89%) |
Net Cash Flow from Operations | -CHF11,511,064 (-32.57%) | -CHF8,683,231 (36.49%) | -CHF13,672,738 (-182.29%) | -CHF4,843,470 (42.29%) |
Net Cash Flow / Change in Cash & Cash Equivalents | CHF555,420 (155.93%) | -CHF993,073 (90.60%) | -CHF10,564,070 (-207.77%) | CHF9,802,625 (344.08%) |
Net Cash Flow - Business Acquisitions and Disposals | CHF1,434,324 (0%) | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | CHF10,040 (0%) | CHF0 (0%) | -CHF179,104 (0%) | CHF0 (0%) |
Capital Expenditure | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) |
Issuance (Repayment) of Debt Securities | CHF1,049,025 (-82.29%) | CHF5,924,376 (8723.55%) | -CHF68,700 (-104.51%) | CHF1,522,931 (204.07%) |
Issuance (Purchase) of Equity Shares | CHF10,507,223 (165.16%) | CHF3,962,618 (-42.09%) | CHF6,842,940 (-57.43%) | CHF16,074,996 (64.14%) |
Payment of Dividends & Other Cash Distributions | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) |
Effect of Exchange Rate Changes on Cash | CHF46,594 (91.93%) | CHF24,277 (-91.61%) | CHF289,391 (304.60%) | CHF71,525 (823.62%) |
Share Based Compensation | CHF379,414 (10.68%) | CHF342,799 (-71.58%) | CHF1,206,303 (227.09%) | CHF368,793 (62.75%) |
Depreciation Amortization & Accretion | CHF119,304 (0.35%) | CHF118,887 (55.70%) | CHF76,357 (281.10%) | CHF20,036 (-35.00%) |
CYTOF Financial Metrics (MRY)
Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
Gross Margin | - | -372.40% (89.07%) | -3407.30% | - |
Profit Margin | - | -8680.30% (67.49%) | -26703.10% | - |
EBITDA Margin | - | -8346.40% (68.21%) | -26252.70% | - |
Return on Average Equity (ROAE) | 416.90% (137.10%) | -1123.70% (-881.40%) | -114.50% (-59.25%) | -71.90% (47.48%) |
Return on Average Assets (ROAA) | -55.30% (73.45%) | -208.30% (-143.91%) | -85.40% (-56.41%) | -54.60% (21.33%) |
Return on Sales (ROS) | - | -8385.30% (68.20%) | -26372.30% | - |
Return on Invested Capital (ROIC) | 250.00% (-77.72%) | 1122.00% (-16.94%) | 1350.80% (174.22%) | 492.60% (22.51%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.37 (-139.35%) | -0.15 (87.91%) | -1.28 (29.75%) | -1.82 (86.76%) |
Price to Sales Ratio (P/S) | - | 12.59 (-96.43%) | 352.74 | - |
Price to Book Ratio (P/B) | 0.18 (138.88%) | -0.46 (-126.78%) | 1.73 (148.42%) | 0.7 (42.62%) |
Debt to Equity Ratio (D/E) | 0.19 (110.86%) | -1.76 (-473.25%) | 0.47 (96.25%) | 0.24 (-54.55%) |
Earnings Per Share (EPS) | -7.88 (72.95%) | -29.13 (-13.08%) | -25.76 (-1.94%) | -25.27 (-1008.33%) |
Sales Per Share (SPS) | 0 (0%) | 0.39 (273.79%) | 0.1 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -28.94 (-184.41%) | -10.18 (49.22%) | -20.04 (-4.67%) | -19.15 (78.78%) |
Book Value Per Share (BVPS) | 16.24 (266.65%) | -9.74 (-150.99%) | 19.11 (-71.17%) | 66.3 (2.96%) |
Tangible Assets Book Value Per Share (TABVPS) | 9.56 (238.39%) | 2.82 (-60.33%) | 7.12 (-84.59%) | 46.19 (75.97%) |
Enterprise Value Over EBIT (EV/EBIT) | -2 (0%) | 0 (0%) | -1 (0.00%) | -1 (0%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -2.11 (-525.52%) | -0.34 (60.07%) | -0.84 (41.67%) | -1.45 (-454.66%) |
Asset Turnover | 0 (0%) | 0.02 (700.00%) | 0 (0%) | 0 (0%) |
Current Ratio | 1.38 (904.38%) | 0.14 (-83.73%) | 0.84 (-78.04%) | 3.83 (267.95%) |
Dividends | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) | CHF0 (0%) |
Free Cash Flow (FCF) | -CHF11,511,064 (-32.57%) | -CHF8,683,231 (36.49%) | -CHF13,672,738 (-182.29%) | -CHF4,843,470 (42.73%) |
Enterprise Value (EV) | CHF5,223,737 (-43.48%) | CHF9,241,571 (-40.60%) | CHF15,559,022 (17.29%) | CHF13,265,736 (566.62%) |
Earnings Before Tax (EBT) | -CHF3,869,173 (85.42%) | -CHF26,538,740 (-55.77%) | -CHF17,036,823 (-107.22%) | -CHF8,221,449 (-20.45%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -CHF2,081,394 (91.84%) | -CHF25,507,984 (-52.10%) | -CHF16,770,771 (-107.91%) | -CHF8,066,262 (-19.21%) |
Invested Capital | CHF2,393,914 (157.62%) | -CHF4,154,700 (-904.62%) | -CHF413,560 (80.13%) | -CHF2,080,911 (-73.08%) |
Working Capital | CHF334,240 (103.01%) | -CHF11,110,678 (-1344.96%) | -CHF768,925 (-108.95%) | CHF8,587,402 (8864.26%) |
Tangible Asset Value | CHF3,800,578 (57.76%) | CHF2,409,084 (-50.38%) | CHF4,855,444 (-58.44%) | CHF11,683,957 (374.85%) |
Market Capitalization | CHF1,383,997 (-66.55%) | CHF4,138,083 (-83.29%) | CHF24,762,281 (86.82%) | CHF13,254,800 (336.42%) |
Average Equity | -CHF928,047 (-139.31%) | CHF2,360,720 (-84.16%) | CHF14,903,070 (30.69%) | CHF11,403,012 (135.46%) |
Average Assets | CHF6,998,512 (-45.05%) | CHF12,736,543 (-36.27%) | CHF19,984,844 (33.12%) | CHF15,012,759 (57.18%) |
Invested Capital Average | -CHF880,393 (61.46%) | -CHF2,284,130 (-83.14%) | -CHF1,247,236 (24.02%) | -CHF1,641,581 (2.90%) |
Shares | 397,700 (-53.39%) | 853,213 (25.08%) | 682,156 (169.68%) | 252,954 (169.85%) |
